Soral indications
Oral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Parenteral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
Uses of Soral in details
Soral is used to reduce pain and inflammation (swelling) of the muscles, tendons, and joints in diseases like arthritis or in short-term injuries, strains, or sprains.
Soral description
Novo-Soral, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.
Soral dosage
Oral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Parenteral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
Soral interactions
FELDENE is highly protein bound, and therefore, might be expected to displace other protein-bound drugs. Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.
Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels.
Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. It is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing FELDENE.
Soral side effects
Cardiovascular
Edema; weight gain; CHF; alterations in BP; vasodilation; palpitations; tachycardia.
CNS
Headache; malaise; dizziness; somnolence; vertigo; depression; insomnia; nervousness.
Dermatologic
Pruritus; rash; sweating; erythema; bruising; desquamation; erythema multiforme; toxic epidermal necrolysis.
EENT
Tinnitus; swollen eyes; blurred vision; eye irritation; rhinitis; pharyngitis.
GI
Epigastric distress; nausea; vomiting; anorexia; constipation; stomatitis; abdominal discomfort; diarrhea; flatulence; abdominal pain; indigestion; toxicity (bleeding, ulceration, perforation); heartburn; dyspepsia; anorexia.
Genitourinary
Hematuria; proteinuria; increased BUN and serum creatinine; acute renal insufficiency and failure; papillary necrosis; interstitial nephritis; nephrotic syndrome; hyperkalemia; hyponatremia.
Hematologic
Increased bleeding time; decreased Hgb and Hct; anemia; leukopenia; eosinophilia, thrombocytopenia.
Hepatic
Increased LFTs; elevated liver enzymes.
Respiratory
Bronchospasm; laryngeal edema; dyspnea; hemoptysis; shortness of breath.
Soral contraindications
Hypersensitivity to Soral, aspirin or other NSAIDs. History of or active peptic ulceration, GI bleeding (melaena, haematemesis) or severe gastritis; severe heart failure. Last trimester of pregnancy.
Active ingredient matches for Soral:
Tenoxicam in Greece.
List of Soral substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Sinoral (Thailand) | |
| Sinoral 20 mg x 25 x 10's (Biolab) | |
| Sutondin (Taiwan) | |
| Sutondin 10 mg | |
| Sutondin 20 mg x 1000's | |
| Tecam (Venezuela) | |
| Teconam (Thailand) | |
| Teconam 20 mg x 500's (Asian pharm) | |
| Tefarel (Ecuador) | |
| Teflan (Brazil) | |
| Teksamen (Georgia) | |
| Teksamen-L (Georgia) | |
| Tenalgin (Portugal) | |
| Tenax (Thailand) | |
| Tenax 20 mg x 100's (Siam Bheasach) | |
| Tenax 20 mg x 500's (Siam Bheasach) | |
| Tenax FC tab 20 mg 10 x 10's (Siam Bheasach) | |
| Tencam (Taiwan) | |
| Tencam 20 mg x 100's | |
| Tencam 20 mg x 10's | |
| Tenikam (Georgia) | |
| Tenobio (Brazil) | |
| Tenocam (South Korea, Thailand) | |
| Tenocam 20 mg x 250's (Eurofarma) | |
| Tenogesic (Thailand) | |
| Tenogesic 20 mg x 10 x 10's | |
| Tenoksan (Turkey) | |
| Tenoktil (Turkey, Yemen) | |
| Tenoliof (Georgia) | |
| Tenorix (Bangladesh) | |
| Tenostad (Vietnam) | |
| Tenostad 20 mg x 1 Bottle in 1 tube dung mobi | |
| Tenotec (Brazil) | |
| Tenotil (Vietnam) | |
| Tenotil 20 mg x 10 Tablet | |
| Tenotil 20 mg x 30 Tablet | |
| Tenotil 20 mg x 50 Tablet | |
| Tenotil 20 mg x 100 Tablet | |
| Tenotil 20 mg x 500 Tablet | |
| Tenotil 20 mg x 1000 Tablet | |
| Tenox (Bosnia & Herzegowina, Bulgaria, Croatia (Hrvatska), Finland, Georgia, Hungary, Ireland, Latvia, Lithuania, Poland, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Thailand, Turkey) | |
| Tablet; Oral; Amlodipine Maleate 10 mg (KRKA) | |
| Tablet; Oral; Amlodipine Maleate 5 mg (KRKA) | |
| Tenox 5mg - 30 Tablets (KRKA) | $ 22.70 |
| Tenox 10mg - 30 Tablets (KRKA) | $ 25.00 |
| Tenox 20 mg x 20 x 10's (KRKA) | |
| Tenox tab 10 mg 30's (KRKA) | |
| Tenox tab 5 mg 30's (KRKA) | |
| Tenoxam (Yemen) | |
| Tenoxen (Brazil) | |
| Tenoxicam (Belgium, Bulgaria, Denmark, France, Iceland, Italy, Japan, Lithuania, Luxembourg, New Zealand, Romania, Switzerland, Turkey) | |
| Tablet; Oral; Tenoxicam 20 mg (Arena group) | |
| Capsule; Oral; Tenoxicam 20 mg (Arena group) | |
See 243 substitutes for Soral | |
References
- PubChem. "tenoxicam". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "tenoxicam". http://www.drugbank.ca/drugs/DB00469 (accessed September 17, 2018).
- DTP/NCI. "tenoxicam: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Soral are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Soral. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Soral drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Not useful | 1 | 100.0% | |
Consumer reported price estimates
No survey data has been collected yet1 consumer reported time for results
To what extent do I have to use Soral before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 2 days and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Soral. To get the time effectiveness of using Soral drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 2 days | 1 | 100.0% | |
1 consumer reported age
| Users | % | ||
|---|---|---|---|
| 46-60 | 1 | 100.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
